ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $935,043 | -83.6% | 43,269 | -85.3% | 0.00% | -100.0% |
| Q3 2022 | $5,694,000 | +79.1% | 294,071 | +83.8% | 0.00% | 0.0% |
| Q2 2022 | $3,179,000 | -16.6% | 160,021 | +25.2% | 0.00% | 0.0% |
| Q1 2022 | $3,812,000 | +97.1% | 127,806 | +53.9% | 0.00% | – |
| Q4 2021 | $1,934,000 | -19.8% | 83,043 | +7.5% | 0.00% | – |
| Q3 2021 | $2,412,000 | +32.8% | 77,271 | +49.6% | 0.00% | – |
| Q2 2021 | $1,816,000 | +75.3% | 51,635 | +75.6% | 0.00% | – |
| Q1 2021 | $1,036,000 | -66.5% | 29,400 | -64.3% | 0.00% | – |
| Q4 2020 | $3,090,000 | -67.4% | 82,372 | -71.0% | 0.00% | -100.0% |
| Q3 2020 | $9,475,000 | +1249.7% | 283,921 | +971.6% | 0.00% | – |
| Q2 2020 | $702,000 | +296.6% | 26,495 | +145.6% | 0.00% | – |
| Q1 2020 | $177,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |